Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Tianzhu Yu, Guoping Li, Chenggang Wang, Gaoquan Gong, Liangwen Wang, Changyu Li, Yi Chen & Xiaolin Wang. (2021) MIR210HG regulates glycolysis, cell proliferation, and metastasis of pancreatic cancer cells through miR-125b-5p/HK2/PKM2 axis. RNA Biology 18:12, pages 2513-2530.
Read now
Read now
Articles from other publishers (21)
S. Afsar, Rahamat Unissa Syed, Mohammed Khaled Bin Break, Ruba Hamoud Alsukaybi, Reem A. Alanzi, Abeer Mohammed alshobrmi, Noura Mohammad Alshagdali, Ammar D. Alshammari, Fayez Mohammed Alharbi, Abdulaziz Mutlaq Alshammari, Wadaah F. Algharbi, Khadijah Mansour Albrykan & Fayhaa Nafea Alshammari. (2024) The dual role of MiR-210 in the aetiology of cancer: A focus on hypoxia-inducible factor signalling. Pathology - Research and Practice 253, pages 155018.
Crossref
Crossref
Mutian Lian, Maria Mortoglou & Pinar Uysal-Onganer. (2023) Impact of Hypoxia-Induced miR-210 on Pancreatic Cancer. Current Issues in Molecular Biology 45:12, pages 9778-9792.
Crossref
Crossref
Yingping Zeng, Guangtao Song, Shufen Zhang, Sufen Li, Tingting Meng, Hong Yuan & Fuqiang Hu. (2023) GSH-Responsive Polymeric Micelles for Remodeling the Tumor Microenvironment to Improve Chemotherapy and Inhibit Metastasis in Breast Cancer. Biomacromolecules 24:11, pages 4731-4742.
Crossref
Crossref
Naotake Funamizu, Masahiko Honjo, Kei Tamura, Katsunori Sakamoto, Kohei Ogawa & Yasutsugu Takada. (2023) microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer. Cancers 15:4, pages 1230.
Crossref
Crossref
Lesetja Motadi, Mzubanzi Mabongo, Demetra Demetriou, Precious Mathebela & Zodwa Dlamini. 2023. Artificial Intelligence and Precision Oncology. Artificial Intelligence and Precision Oncology
73
91
.
Jichuan Xu, Jian Xu, Xinyuan Liu & Jianxin Jiang. (2022) The role of lncRNA-mediated ceRNA regulatory networks in pancreatic cancer. Cell Death Discovery 8:1.
Crossref
Crossref
Kateryna Nesteruk, Iris J.M. Levink, Esther de Vries, Isis J. Visser, Maikel P. Peppelenbosch, Djuna L. Cahen, Gwenny M. Fuhler & Marco J. Bruno. (2022) Extracellular vesicle-derived microRNAs in pancreatic juice as biomarkers for detection of pancreatic ductal adenocarcinoma. Pancreatology 22:5, pages 626-635.
Crossref
Crossref
Tomas Koltai, Stephan Joel Reshkin, Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, Khalid Omer Alfarouk & Rosa Angela Cardone. (2022) Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. Cancers 14:10, pages 2486.
Crossref
Crossref
Apostolis Papaefthymiou, Aris Doukatas & Michail Galanopoulos. (2022) Pancreatic cancer and oligonucleotide therapy: Exploring novel therapeutic options and targeting chemoresistance. Clinics and Research in Hepatology and Gastroenterology 46:5, pages 101911.
Crossref
Crossref
Germana Zaccagnini, Simona GrecoChristine VoellenkleCarlo GaetanoFabio Martelli. (2022) miR-210 hypoxamiR in Angiogenesis and Diabetes. Antioxidants & Redox Signaling 36:10-12, pages 685-706.
Crossref
Crossref
Annalisa Comandatore, Benoit Immordino, Rita Balsano, Mjriam Capula, Ingrid Garajovà, Joseph Ciccolini, Elisa Giovannetti & Luca Morelli. (2022) Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer. Diagnostics 12:2, pages 286.
Crossref
Crossref
Lusine Demirkhanyan & Christopher S. Gondi. 2022. Clinical Applications of Non-Coding RNAs in Cancer. Clinical Applications of Non-Coding RNAs in Cancer
1
16
.
Nihad Boukrout, Mouloud Souidi, Fatima Lahdaoui, Belinda Duchêne, Bernadette Neve, Lucie Coppin, Emmanuelle Leteurtre, Jérôme Torrisani, Isabelle Van Seuningen & Nicolas Jonckheere. (2021) Antagonistic Roles of the Tumor Suppressor miR-210-3p and Oncomucin MUC4 Forming a Negative Feedback Loop in Pancreatic Adenocarcinoma. Cancers 13:24, pages 6197.
Crossref
Crossref
Yaashini Rajasegaran, Adam Azlan, Aliaa Arina Rosli, Mot Yee Yik, Khor Kang Zi, Narazah Mohd Yusoff & Emmanuel Jairaj Moses. (2021) Footprints of microRNAs in Cancer Biology. Biomedicines 9:10, pages 1494.
Crossref
Crossref
Adriana Fodor, Andrada Luciana Lazar, Cristina Buchman, Brandusa Tiperciuc, Olga Hilda Orasan & Angela Cozma. (2021) MicroRNAs: The Link between the Metabolic Syndrome and Oncogenesis. International Journal of Molecular Sciences 22:12, pages 6337.
Crossref
Crossref
Kakeru Hisakane, Masahiro Seike, Teppei Sugano, Akiko Yoshikawa, Kuniko Matsuda, Natsuki Takano, Satoshi Takahashi, Rintaro Noro & Akihiko Gemma. (2021)
Exosome‐derived
miR
‐210 involved in resistance to osimertinib and epithelial–mesenchymal transition in
EGFR
mutant non‐small cell lung cancer cells
. Thoracic Cancer 12:11, pages 1690-1698.
Crossref
Crossref
Rongli Wang, Li Zou & Xinyuan Yang. (2021) microRNA-210/ Long non-coding RNA MEG3 axis inhibits trophoblast cell migration and invasion by suppressing EMT process. Placenta 109, pages 64-71.
Crossref
Crossref
Fei Xu, Heshui Wu, Jiongxin Xiong & Tao Peng. (2021) Long Non-coding RNA DLEU2L Targets miR-210-3p to Suppress Gemcitabine Resistance in Pancreatic Cancer Cells via BRCA2 Regulation. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Jinxin Tao, Gang Yang, Wenchuan Zhou, Jiangdong Qiu, Guangyu Chen, Wenhao Luo, Fangyu Zhao, Lei You, Lianfang Zheng, Taiping Zhang & Yupei Zhao. (2021) Targeting hypoxic tumor microenvironment in pancreatic cancer. Journal of Hematology & Oncology 14:1.
Crossref
Crossref
Claudia Geismann & Alexander Arlt. (2020) Coming in the Air: Hypoxia Meets Epigenetics in Pancreatic Cancer. Cells 9:11, pages 2353.
Crossref
Crossref
Jingwen Ma, Xiaohua Tao & Youming Huang. (2020) Silencing microRNA-210 in Hypoxia-Induced HUVEC-Derived Extracellular Vesicles Inhibits Hemangioma. Cerebrovascular Diseases 49:5, pages 462-473.
Crossref
Crossref